RVL Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for RVL Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 23.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
RVL Pharmaceuticals plc (NASDAQ:RVLP) Analysts Just Cut Their EPS Forecasts Substantially
Aug 16
Analysts Just Made A Major Revision To Their RVL Pharmaceuticals plc (NASDAQ:RVLP) Revenue Forecasts
May 13RVL Pharmaceuticals plc (NASDAQ:RVLP) Doing What It Can To Lift Shares
May 12RVL Pharmaceuticals (NASDAQ:RVLP) Is Making Moderate Use Of Debt
Apr 20Is RVL Pharmaceuticals (NASDAQ:RVLP) Using Debt Sensibly?
Jan 05RVL Pharmaceuticals sees Q3 net sales of UPNEEQ for eye treatment about $10M
Oct 18RVL Pharmaceuticals: Chapter 2 - A Developing Quandary
Sep 22RVL Pharma in pact with Revision Skincare to broaden access to products
Aug 30GAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M
Aug 11RVL Pharma posts preliminary 42% sales growth for eye treatment
Jul 07RVL Pharmaceuticals (NASDAQ:RVLP) Is Carrying A Fair Bit Of Debt
Jul 04RVL Pharmaceuticals: Chapter 1 Gives A Mixed Picture
Jun 15New Forecasts: Here's What Analysts Think The Future Holds For RVL Pharmaceuticals plc (NASDAQ:RVLP)
Apr 01RVL Pharmaceuticals: A Makeover For An Ugly Duckling
Mar 30Osmotica: A Different Breed Of Cat
Dec 14Osmotica Pharmaceuticals (NASDAQ:OSMT) Takes On Some Risk With Its Use Of Debt
Aug 20Osmotica: Paring Down, Focusing On UPNEEQ
Jul 16These 4 Measures Indicate That Osmotica Pharmaceuticals (NASDAQ:OSMT) Is Using Debt Extensively
May 05In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RVL Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 37 | -68 | -47 | -44 | N/A |
| 3/31/2023 | 37 | -56 | -32 | -30 | N/A |
| 12/31/2022 | 50 | -52 | -39 | -38 | N/A |
| 9/30/2022 | 43 | -53 | -46 | -46 | N/A |
| 6/30/2022 | 35 | -66 | -52 | -52 | N/A |
| 3/31/2022 | 38 | -76 | -58 | -57 | N/A |
| 12/31/2021 | 18 | -83 | -49 | -55 | N/A |
| 9/30/2021 | 16 | -115 | -34 | -39 | N/A |
| 6/30/2021 | 40 | -86 | -9 | -13 | N/A |
| 3/31/2021 | 28 | -82 | 11 | 6 | N/A |
| 12/31/2020 | 28 | -89 | 15 | 18 | N/A |
| 9/30/2020 | 87 | -64 | 23 | 27 | N/A |
| 6/30/2020 | 126 | -178 | 51 | 54 | N/A |
| 3/31/2020 | 183 | -285 | 35 | 40 | N/A |
| 12/31/2019 | 240 | -271 | 30 | 34 | N/A |
| 9/30/2019 | 246 | -351 | 59 | 63 | N/A |
| 6/30/2019 | 247 | -243 | 29 | 33 | N/A |
| 3/31/2019 | 261 | -112 | 21 | 24 | N/A |
| 12/31/2018 | 264 | -110 | 33 | 38 | N/A |
| 9/30/2018 | 274 | -1 | 14 | 29 | N/A |
| 6/30/2018 | 262 | -10 | 3 | 19 | N/A |
| 3/31/2018 | 248 | -31 | 27 | 45 | N/A |
| 12/31/2017 | 246 | -41 | 38 | 58 | N/A |
| 12/31/2016 | 218 | -42 | N/A | -45 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if RVLP.Q's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if RVLP.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if RVLP.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if RVLP.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if RVLP.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RVLP.Q's Return on Equity is forecast to be high in 3 years time